However, in the P-SPIRIT 2 study with the same molecule in PsA cases that failed to respond to prior TNF blockade, there was no significant effect on enthesitis at the pre-specified 24-week assessment, but there was evidence for efficacy at earlier time points [57]. The gene discussed is TNF; the disease is enthesitis.